Beginning on June 1, Germany will accept COVAXIN from Bharat Biotech for use in travel

The WHO-listed COVID vaccination COVAXIN from Bharat Biotech has been approved by the German government for use beginning on June 1 in travel to India, according to Walter J Lindner, the German ambassador to India. In November of last year, the World Health Organization (WHO) added COVAXIN to its...

JAPAN’S DAIICHII BIOTECH STARTS MANUFCATURING ASTRAZENECA’S COVID-19 VACCINE

Highlights –

• Japan’s Daiichi Biotech starts manufacturing AstraZeneca’s COVID-19 vaccine.
• The Japanese drugmaker has begun manufacturing the vaccine based on an outsourcing agreement.
• The vaccine will be supplied after gai...

MICROBIOME BIOTECH FIRM GENOME & COMPANY AWAIT FINAL WORD BEFORE IPO ON KOSDAQ

• Still waiting to go public with its initial public offering (IPO) at tech-intensive KOSDAQ later this year, Genome & Company laid out the biotech firm's various business models and oncoming visions focusing on its microbiome-based immuno-oncology expertise at its IR event on Thurs...

KOREAN BIOTECH AND WELLNESS COMPANIES TO INFUSE 10 TRILLION WON BY 2023

• Korea’s chief biotech and wellness companies, including Samsung Biologics and Celltrion, will pour funds to the tune of 10 trillion won by 2023.
• The Ministry of Trade, Industry and Energy announced its innate tactics to foster the biotech and healthcare industry and bolst...

SOUTH KOREA’S GL RAPHA TO PRODUCE 150 MILLION VIALS OF RUSSIAN COVID-19 VACCINE

• Bio-tech Company GL Rapha has been chosen to produce 150 million doses of Russia's Sputnik V vaccine to battle against the COVID-19 in Korea every year, the Russian Direct Investment Fund (RDIF) said Friday.
• The statement was issued after the RDIF declared in August that Ru...

BIOTECH FIRM GENEXINE VACCINE READY FOR CLINICAL TESTING – COVID-19

Highlights –

• South Korea’s first potential vaccine is ready for clinical testing.
• Biotech firm Genexine has developed the potential vaccine.
• GX-19 is the name of the vaccine.
• The firm will apply for clinical testing ...

Puma Biotech Inc. is looking forward to going to the top

EPS is the part of a company’s interest allotted to each outstanding share of natural accretion. EPS works as a gauge of a company’s profitability. EPS is usually thought to be and no-one else various important variables in circumscribing a share price.

In summary, for the n...

Biotech pioneers perceived by Industry Excellence Awards

Industry Excellence Awards were declared today at the AusBiotech 2019 national meeting in Melbourne. The AusBiotech and Johnson and Johnson Innovation Industry Excellence Awards perceive inventive organizations and people in Australia's reality class biotechnology, therapeutic innovation, and...

Australian biotech working for cancers

The Australian biotech scene has been all the rage in the biotech industry of the world as the biotechnology from Australia has changed the perspective of the world on the sector. The developments that it has made in such a short period of time has made it an example of how to develop the biotech...

US legislator resigns over a scandal involving the Australian biotech firm

A United States legislator has resigned when deciding to plead guilty to trading charges associated with associate Australian biotechnology firm.

Chris Collins was a Republican legislator from a Sydney-based firm and Innate Immunotherapeutics on the company's board.

Prosec...

A new event to aid the bio industry

Australia has been growing and emerging as a biotechnology hub and the nation has more potential to grow and if it works the way it has been working now it will become a leader in the industry for sure at a global stage.

Recognizing the biotechnology potential of the nation of Australia...

A new framework to power the biotech scene

The Australian Biotechnology 2030 Vision is a policy framework for the biotechnology industry which is discussed by Minister Hunt and is supported by Minister Andrews, at the AusBiotech CEO Policy Forum that took place in Canberra last week. Using the assistance of Minister Hunt that has committe...

Biotech Pharma dares an IPO

 In the time, when IPOs (Initial Public Offering) are facing huge financial issues while they debut on the world markets there are some daring to do so and as they say, risk-takers are money makers might just come through for these daring IPOs. The German developer of individualized treatmen...

New biotech launch to help the biotech trade

The Australian biotech is ever-changing and therefore the trade is growing as new technologies ar being introduced and new researches ar being spawned within the biotechnology trade of the state. Biotechnology major Biocon a...

New merger to help biotech growth in Australia

The Australian Biotech scene is there for EME what developing and that we expect it to develop quite considerably into an enormous trade and a authoritative one because it has the potential to try and do so. Australian biotech&...